| Original language | English |
|---|---|
| Pages (from-to) | 39-40 |
| Number of pages | 2 |
| Journal | Evidence-based Medicine |
| Volume | 16 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Apr 2011 |
For type 2 diabetes poorly controlled by metformin monotherapy, the addition of any non-insulin antidiabetic drug reduces HbA1c to a similar extent, but with differing effects on weight and hypoglycaemic risk
Research output: Contribution to journal › Article › peer-review